Honey/Vinegar
Ivermectin
Matching similarly attributes, side effects.
Ivermectin is primarily an antiparasitic drug, not a standard treatment for allergies, but studies show it has anti-inflammatory properties that may help reduce specific, underlying allergy-type symptoms.
Anti-inflammatory Effects: Research indicates ivermectin can reduce inflammation, including airway inflammation in models of allergic asthma.
Addressing "Occult" Parasitic Infections
In some cases, chronic "allergy" symptoms (like hives, itching, or asthma) are actually caused by an undiagnosed parasitic infection, such as Strongyloides.
..
Ivermectin
Dog Toxicity
Degenerative Myelopathy
Amyotrophic Lateral Sclerosis (ALS)
P-Glycoprotein
Transporter Pump
Copper-Zinc
Superoxide Dismutase
MDR1 Allele Mutation
NOG Gene Mutation
SOD1 Gene Mutation
Mutations in the SOD1 gene are a significant genetic cause of familial amyotrophic lateral sclerosis (ALS), responsible for 10–20% of such cases. These mutations cause misfolded protein accumulation, leading to motor neuron degeneration.
SOD1 is located on chromosome 21, it is often tested alongside other markers.
QALSODY (tofersen) is an FDA-approved treatment for this mutation.
Key Aspects of SOD1 Gene Mutation (ALS):
Pathology: Over 200 pathogenic mutations in the copper-zinc superoxide dismutase (SOD1) gene have been reported.
Mechanism: Misfolded SOD1 proteins accumulate, causing toxic gain-of-function rather than just a loss of protein function.
Pathology: Over 200 pathogenic mutations in the copper-zinc superoxide dismutase (SOD1) gene have been reported.
Mechanism: Misfolded SOD1 proteins accumulate, causing toxic gain-of-function rather than just a loss of protein function.
Treatment: Tofersen (Qalsody) is an antisense oligonucleotide (ASO) therapy that targets and reduces toxic SOD1 protein.
Tofersen (Qalsody) Chemical Similarly
B-Vitamins (Nitrogen)
Vitamin C (Oxygen)
MSM (Sulfur)
Zinc / Copper
..
Positive Allosteric Modulators (PAMs)
Glutamate-Gated Chloride Channels
Orthosteric Agonist
Leftward Shift
Cannabinoid Positive Allosteric Modulators (PAMs) are a class of compounds that enhance the activity of cannabinoid receptors (primarily CB1 and CB2) by binding to a site distinct from the main orthosteric pocket. Unlike traditional agonists like THC, pure PAMs do not activate the receptor on their own; instead, they amplify the effects of endogenous cannabinoids (endocannabinoids) already present in the body.
Therapeutic Advantages: The primary appeal of cannabinoid PAMs is their potential to provide medical benefits without the "high" or other adverse effects associated with direct receptor activation.